PCORI Names WellPoint’s Alan Rosenberg to Advisory Panel

PCORI Names WellPoint’s Alan Rosenberg to Advisory Panel

<0> WellPoint, Inc.Lori McLaughlin, 317.407.7403 </0>

The Patient-Centered Outcomes Research Institute Board of Governors appointed WellPoint’s Dr. Alan Rosenberg to the Assessment of Prevention, Diagnosis and Treatment Options panel.

PCORI, authorized by Congress, is charged with conducting research and providing information about the best available evidence to help patients and their health care providers make more informed decisions.

Rosenberg, vice president of clinical pharmacy and medical policy, was one of more than 1,000 applicants for positions on the four committees. The Assessment of Prevention, Diagnosis and Treatment Options panel will identify and prioritize comparative research topics, provide feedback to PCORI on specific research questions and study designs, comment on PCORI’s research portfolio and provide input on PCORI’s research priorities.

“WellPoint is pleased to share Dr. Rosenberg’s expertise with PCORI,” said Dr. Sam Nussbaum, WellPoint chief medical officer. “As a highly informed and thoughtful clinician and as the leader of WellPoint’s clinical pharmacy and medical policy programs, Dr. Rosenberg brings valuable knowledge to help represent patients and doctors, who are expected to use PCORI’s information to help improve care. Also, he brings the perspective of heath benefits companies, which are constantly monitoring the efficacy and effectiveness of drugs, devices and procedures and aware of key gaps in medical evidence.”

The appointment is a one-year term, with the possibility of reappointment for a maximum of two terms.

“I hope to bring what I’ve learned from working directly with patients and patient advocates to this broad-based panel,” Rosenberg said. “I look forward to offering input on the front end of research, as we see many research questions that, if answered, could greatly assist us in developing policies to help improve members’ health.”

At WellPoint, we believe there is an important connection between our members’ health and well-being—and the value we bring our customers and shareholders. So each day we work to improve the health of our members and their communities. And, we can make a real difference since we have more than 36 million people in our affiliated health plans, and nearly 67 million people served through our subsidiaries. As an independent licensee of the Blue Cross and Blue Shield Association, WellPoint serves members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as the Blue Cross Blue Shield licensee in 10 New York City metropolitan and surrounding counties and as the Blue Cross or Blue Cross Blue Shield licensee in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), and Wisconsin. In a majority of these service areas, WellPoint’s plans do business as Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia and Empire Blue Cross Blue Shield, or Empire Blue Cross (in the New York service areas). WellPoint also serves customers throughout the country as UniCare and in certain markets through our Amerigroup and CareMore subsidiaries. Our 1-800 CONTACTS, Inc. subsidiary offers customers online sales of contact lenses, eyeglasses and other ocular products. Additional information about WellPoint is available at .